| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/13/2008 | CN100367995C Receipt of 'Mailuoxin' capsule, and preparation method |
| 02/13/2008 | CN100367992C Hypotensive pillow |
| 02/13/2008 | CN100367991C Daphne freeze-drying powder injection and its preparation method |
| 02/13/2008 | CN100367987C Quality control method of eucommia bark blood pressure lowering preparation for treating high blood pressure |
| 02/13/2008 | CN100367982C Method for producing ointmen for treating hemorrhoids |
| 02/13/2008 | CN100367981C Medicine for treating cardio vascular disease |
| 02/13/2008 | CN100367969C Injection formulation of astragalus root saponin and its preparation mehod |
| 02/13/2008 | CN100367967C Fasudic hydrochloride oral formulation |
| 02/13/2008 | CN100367964C Inclusion preparation of levosimendan and beta cyclodextrin |
| 02/13/2008 | CN100367963C Medicinal composition containing bilobalide B and its preparation process and usage |
| 02/13/2008 | CN100367961C Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| 02/13/2008 | CN100367959C Medicine contg. irbesartan |
| 02/13/2008 | CN100367956C Medicine for treating hypertension |
| 02/13/2008 | CN100367951C Butyl benzene phthalein vein emulsion and its application |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367944C Allicin microcapsule and its preparation method |
| 02/13/2008 | CN100367938C Sihuang intense heat purging dripping pill and its preparing method |
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329761 Substituted imides |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329751 Process for the preparation of clopidogrel |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction |
| 02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
| 02/12/2008 | CA2321122C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/12/2008 | CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008016924A2 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 02/07/2008 | WO2008016884A2 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | WO2008016883A2 Inhibitors of plasma kallikrein |
| 02/07/2008 | WO2008016640A2 Use of poloxamer for the prevention and/or treatment of heart failure |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008015950A1 Acat inhibitor |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015028A1 Uses and compositions comprising mirnas |
| 02/07/2008 | WO2008014564A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | WO2007120930A3 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 02/07/2008 | WO2007120523A8 6-(aminoalkyl)indazoles |
| 02/07/2008 | WO2007098503A3 Aliskiren nitrate salt |
| 02/07/2008 | US20080033376 Hot flash treatment system |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033040 Methods And Compositions For Screening Involving Endothelial Cells Under Shearing Conditions |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/07/2008 | US20080033019 Cholesterol lowering drug combination |
| 02/07/2008 | US20080033016 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 02/07/2008 | US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032993 Substituted heterocyclic compounds |
| 02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032959 Estrogen Receptor Modulators |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032954 Vascular Damaging Agents for Administration as an Intravenous Infusion |
| 02/07/2008 | US20080032952 Combination Therapies Employing Nicotinic Acid Derivatives or Fibric Acid Derivatives |
| 02/07/2008 | US20080032934 Compositions for prevention of adhesions and other barrier applications |
| 02/07/2008 | US20080032929 N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032915 Cysteine Rich Peptides for Improving Thiol Homeostasis |
| 02/07/2008 | US20080031978 Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders |
| 02/07/2008 | US20080031970 Method of Promoting Natural Bypass |
| 02/07/2008 | US20080031918 Barriers for polymeric coatings |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031857 Cardiomyocyte Differentiation |
| 02/07/2008 | US20080031827 Injectables in foam. New Pharmaceutical applications |
| 02/07/2008 | US20080031818 Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases |
| 02/07/2008 | DE102006036579A1 Composition, useful to treat hypertension, comprises nebivolol as active agent and a polymer carrier material, where the active agent is present in micronized form in a polymer carrier matrix and is essentially free of wetting agent |
| 02/07/2008 | CA2659909A1 Treatment for chronic progressive heart failure |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2659364A1 Identification of a micro-rna that activates expression of .beta.-myosin heavy chain |
| 02/07/2008 | CA2657120A1 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/06/2008 | EP1884236A1 Angiogenesis inhibitor containing amine derivative as active ingredient |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |